Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
XPENG-W
09868
5
SERES
09927
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -16.12%120.8B | -12.64%82.4B | -8.77%42.44B | -2.76%192.5B | -6.73%144.02B | -4.77%94.32B | -2.46%46.52B | 3.93%197.95B | 8.83%154.41B | 18.37%99.05B |
| Operating income | -16.12%120.8B | -12.64%82.4B | -8.77%42.44B | -2.76%192.5B | -6.73%144.02B | -4.77%94.32B | -2.46%46.52B | 3.93%197.95B | 8.83%154.41B | 18.37%99.05B |
| Cost of sales | ---- | 8.17%-70.48B | ---- | -1.23%-161.61B | ---- | 2.21%-76.75B | ---- | -7.78%-159.65B | ---- | -20.52%-78.48B |
| Operating expenses | 9.60%-99.37B | 8.17%-70.48B | 3.60%-33.87B | -1.23%-161.61B | 2.73%-109.92B | 2.21%-76.75B | 1.01%-35.14B | -7.78%-159.65B | -10.54%-113B | -20.52%-78.48B |
| Gross profit | -37.14%21.43B | -32.16%11.92B | -24.71%8.57B | -19.35%30.89B | -17.65%34.1B | -14.56%17.57B | -6.68%11.39B | -9.53%38.3B | 4.44%41.41B | 10.81%20.57B |
| Selling expenses | 29.93%-5.83B | 9.55%-3.88B | 33.46%-1.76B | 14.89%-8.57B | 20.43%-8.33B | 24.15%-4.29B | 16.17%-2.65B | 9.92%-10.07B | -8.09%-10.46B | -17.79%-5.66B |
| Administrative expenses | 19.00%-1.09B | 14.46%-2.02B | 50.90%-300.49M | 3.46%-4.94B | 20.06%-1.35B | -4.79%-2.37B | -23.07%-611.95M | 4.22%-5.11B | 1.99%-1.68B | 0.34%-2.26B |
| Research and development expenses | 2.78%-1.05B | ---- | -85.37%-306.25M | ---- | -70.37%-1.08B | ---- | 11.18%-165.21M | ---- | -5.42%-634.68M | ---- |
| Profit from asset sales | 101.53%478.38K | ---- | 99.93%-19.34K | ---- | -788.88%-31.35M | ---- | -707.21%-29.67M | ---- | -104.10%-3.53M | ---- |
| Revaluation surplus | 411.49%129.26M | ---- | 2,813.78%79.41M | ---- | 237.01%25.27M | ---- | -93.40%2.73M | ---- | 101.25%7.5M | ---- |
| -Changes in the fair value of other assets | 411.49%129.26M | ---- | 2,813.78%79.41M | ---- | 237.01%25.27M | ---- | -93.40%2.73M | ---- | 101.25%7.5M | ---- |
| Impairment and provision | 91.14%-24.76M | -42.05%-16.35M | 56.86%-10.91M | 82.87%-96.83M | 31.66%-279.56M | 96.14%-11.51M | 2.62%-25.28M | -19.11%-565.22M | 39.64%-409.07M | -245.82%-298.22M |
| -Other impairment is provision | 91.14%-24.76M | -42.05%-16.35M | 56.86%-10.91M | 82.87%-96.83M | 31.66%-279.56M | 96.14%-11.51M | 2.62%-25.28M | -19.11%-565.22M | 39.64%-409.07M | -245.82%-298.22M |
| Special items of operating profit | 134.72%58.64M | 235.67%205.25M | 193.02%101.29M | -717.98%-104.58M | 70.79%-168.89M | -164.19%-151.29M | -173.05%-108.89M | -97.45%16.92M | -91.55%-578.2M | 286.78%235.67M |
| Adjustment items of operating profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0.01 | ---- |
| Operating profit | -49.77%7.84B | -42.31%6.2B | -25.08%4.07B | -23.87%17.18B | -22.76%15.61B | -14.58%10.75B | -11.95%5.43B | -13.23%22.57B | 10.33%20.21B | 9.78%12.59B |
| Financing income | ---- | -29.60%140.96M | ---- | -29.14%372.61M | ---- | -5.10%200.23M | ---- | -20.28%525.83M | ---- | -43.86%211M |
| Financing cost | 29.43%-274.04M | 27.73%-153.99M | 217.76%303.18M | 34.75%-323.04M | 20.38%-388.33M | 22.01%-213.07M | -203.01%-257.46M | 24.81%-495.08M | -178.78%-487.71M | 22.07%-273.19M |
| Special items of earning before tax | ---- | 93.22%-34.18M | ---- | 21.63%-1.25B | ---- | -998.51%-504.31M | ---- | -24.91%-1.6B | ---- | 229.28%56.13M |
| Adjustment items of earning before tax | -105.76%-708.19K | ---- | -1,115.75%-7.75M | ---- | 151.03%12.3M | ---- | 1,750.56%762.87K | ---- | 67.68%-24.11M | ---- |
| Earning before tax | -50.33%7.57B | -39.85%6.16B | -15.66%4.37B | -23.92%15.98B | -22.66%15.24B | -18.65%10.23B | -14.93%5.18B | -15.08%21B | 4.43%19.7B | 9.90%12.58B |
| Tax | 37.50%-3.09B | 29.29%-2.38B | 16.40%-1.41B | 16.68%-6.14B | 23.48%-4.95B | 16.41%-3.37B | 12.65%-1.68B | 12.15%-7.37B | -1.07%-6.46B | -5.93%-4.03B |
| After-tax profit from continuing operations | -56.49%4.48B | -45.03%3.77B | -15.30%2.96B | -27.84%9.83B | -22.26%10.29B | -19.70%6.87B | -16.00%3.49B | -16.58%13.63B | 6.16%13.24B | 11.88%8.55B |
| Earning after tax | -56.49%4.48B | -45.03%3.77B | -15.30%2.96B | -27.84%9.83B | -22.26%10.29B | -19.70%6.87B | -16.00%3.49B | -16.58%13.63B | 6.16%13.24B | 11.88%8.55B |
| Minority profit | -38.44%4.43B | -30.15%3.41B | -17.46%2.03B | -16.22%8.88B | -22.02%7.19B | -14.32%4.89B | -9.05%2.46B | -12.71%10.6B | -0.37%9.22B | 4.03%5.71B |
| Shareholders should account for profits from continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.85B |
| Profit attributable to shareholders | -98.35%51.29M | -81.80%359.96M | -10.20%929.38M | -68.46%955.84M | -22.79%3.1B | -30.49%1.98B | -28.89%1.03B | -27.79%3.03B | 24.96%4.02B | 31.85%2.85B |
| Basic earnings per share | -84.00%0.04 | -68.42%0.12 | -30.56%0.25 | -26.92%0.38 | 33.33%0.36 | |||||
| Diluted earnings per share | -84.00%0.04 | -68.42%0.12 | -30.56%0.25 | -26.92%0.38 | 33.33%0.36 | |||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.